Core Laboratories N.v. (CLB) Tops Q2 EPS by 1c; Guides Q3
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Join SI Premium – FREE
Core Laboratories N.v. (NYSE: CLB) reported Q2 EPS of $1.16, $0.01 better than the analyst estimate of $1.15. Revenue for the quarter came in at $247 million versus the consensus estimate of $251.08 million.
Core Laboratories N.v. sees Q3 2012 EPS of $1.17-$1.25, versus the consensus of $1.24. Core Laboratories N.v. sees Q3 2012 revenue of $250-$260 million, versus the consensus of $263.7 million.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.
Core Laboratories N.v. sees Q3 2012 EPS of $1.17-$1.25, versus the consensus of $1.24. Core Laboratories N.v. sees Q3 2012 revenue of $250-$260 million, versus the consensus of $263.7 million.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Columbus McKinnon names John Linker as CFO, reaffirms FY2027 guidance
- Trump discloses over $1.4 billion in crypto income in 2025 filing
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
